BICX实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 01:22):

Stats
今日成交量	405.00
平均成交量	1 083.00
市值	6.61M
EPS	$0 ( 2024-04-01 )
下一个收益日期	( $0 ) 2024-05-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.670
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-30	Lucido Louis C.	Buy	21 552	Common Stock, par value $0.001
2024-03-28	Galligan Joseph J	Buy	5 566	Common Stock, par value $0.001
2024-01-02	Galligan Joseph J	Buy	6 173	Common Stock, par value $0.001
2024-03-28	Granier Brady James	Buy	16 698	Stock Option
2024-03-28	Murthy Harsha	Buy	5 566	Common Stock, par value $0.001

INSIDER POWER
100.00
Last 98 transactions
Buy: 908 641 \| Sell: 0

BioCorRx Inc. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

BioCorRx Inc. 财务报表

Annual	2023
营收:	$89 160.00
毛利润:	$-146 762 (-164.61 %)
EPS:	$-0.450

FY	2023
营收:	$89 160.00
毛利润:	$-146 762 (-164.61 %)
EPS:	$-0.450

FY	2022
营收:	$213 841
毛利润:	$198 562 (92.85 %)
EPS:	$-0.610

FY	2021
营收:	$48 272.00
毛利润:	$42 391.00 (87.82 %)
EPS:	$-0.810

Financial Reports:

No articles found.

BioCorRx Inc.

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.